{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_003029.4:c.89G>T (p.Arg30Pro)",
          "cDNA Change": {
            "transcript": "NM_003029.4",
            "ref": "G",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_003029.4:c.157T>A (p.Asn53Thr)",
          "cDNA Change": {
            "transcript": "NM_003029.4",
            "ref": "T",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004837"
  },
  "Experiment Method": [
    {
      "Assay Method": "Microarray and quantitative RT-PCR",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cell lines transfected with normal or mutant a-synuclein (A30P, A53T)",
        "Description": "The experiment was conducted using neuroblastoma cell lines transfected with normal or mutant alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_003029.4:c.89G>T (p.Arg30Pro)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial loss-of-function",
          "Result Description": "Mutant A30P a-synuclein caused downregulation of dopamine synthesis genes."
        },
        {
          "Variant": "NM_003029.4:c.157T>A (p.Asn53Thr)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial loss-of-function",
          "Result Description": "Mutant A53T a-synuclein caused downregulation of dopamine synthesis genes."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the abstract."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Gene expression levels comparable to wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly reduced gene expression compared to wild-type controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Microarray and quantitative RT-PCR are standard methods for studying gene expression in PD research."
      }
    }
  ]
}